Indivior reported 317M in Sales Revenues for its fiscal semester ending in March of 2026.





Sales Change Date
AstraZeneca USD 15.38B 90M Jun/2026
GlaxoSmithKline GBP 8.41B 781M Jun/2026
Glaxosmithkline GBP 10.09B 1.37B Mar/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Roche Holding CHF 30.36B 14.71B Jun/2026
West Pharmaceutical Services USD 872.3M 27.4M Jun/2026